Percutaneous treatment of mitral regurgitation by MitraClipTM: report on the first two procedures in Brazil

Revista Brasileira de Cardiologia Invasiva (English Edition) Pub Date : 2015-04-01 DOI:10.1016/j.rbciev.2015.12.018

Fabio S. Brito Jr. , Alexandre Siciliano , Claudio H. Fischer , Marcelo L. Vieira , Arnaldo Rabischoffski , Fabio Papa , Marcelo R. Fernandes , Bernardino Tranchesi Jr. , Paulo Dutra , Marco A. Perin

{"title":"Percutaneous treatment of mitral regurgitation by MitraClipTM: report on the first two procedures in Brazil","authors":"Fabio S. Brito Jr. , Alexandre Siciliano , Claudio H. Fischer , Marcelo L. Vieira , Arnaldo Rabischoffski , Fabio Papa , Marcelo R. Fernandes , Bernardino Tranchesi Jr. , Paulo Dutra , Marco A. Perin","doi":"10.1016/j.rbciev.2015.12.018","DOIUrl":null,"url":null,"abstract":"<div><p>The MitraClip<sup>TM</sup> system has been recently approved for clinical use in Brazil for percutaneous treatment of mitral valve regurgitation. This device is based on the Alfieri surgical procedure, creating a double orifice by bringing together the central segments of the two mitral valve cusps. This report describes the first two procedures performed in Brazil using this device. Two female patients considered to be at high surgical risk due to advanced age and presence of comorbidities were treated, with degenerative mitral regurgitation due to prolapse/flail, associated with <em>chordae tendineae</em> rupture. In both cases, significant mitral regurgitation intensity reduction was obtained using the MitraClip<sup>TM</sup>, demonstrating the great potential of this innovative technology for the percutaneous treatment of mitral valve regurgitation.</p></div>","PeriodicalId":101094,"journal":{"name":"Revista Brasileira de Cardiologia Invasiva (English Edition)","volume":"23 2","pages":"Pages 156-160"},"PeriodicalIF":0.0000,"publicationDate":"2015-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rbciev.2015.12.018","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira de Cardiologia Invasiva (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214123515000447","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

The MitraClip^TM system has been recently approved for clinical use in Brazil for percutaneous treatment of mitral valve regurgitation. This device is based on the Alfieri surgical procedure, creating a double orifice by bringing together the central segments of the two mitral valve cusps. This report describes the first two procedures performed in Brazil using this device. Two female patients considered to be at high surgical risk due to advanced age and presence of comorbidities were treated, with degenerative mitral regurgitation due to prolapse/flail, associated with chordae tendineae rupture. In both cases, significant mitral regurgitation intensity reduction was obtained using the MitraClip^TM, demonstrating the great potential of this innovative technology for the percutaneous treatment of mitral valve regurgitation.

查看原文本刊更多论文

MitraClipTM经皮治疗二尖瓣反流:巴西前两种手术的报告

MitraClipTM系统最近在巴西被批准用于经皮治疗二尖瓣反流的临床应用。该装置基于Alfieri手术程序，通过将两个二尖瓣尖的中心部分连接在一起，形成双孔。本报告描述了在巴西使用该设备执行的前两个程序。两名女性患者由于高龄和合并症的存在而被认为是手术高风险，我们治疗了由于脱垂/连枷导致的退行性二尖瓣反流，并伴有腱索断裂。在这两个病例中，使用MitraClipTM可以显著降低二尖瓣反流强度，这表明了这项创新技术在经皮治疗二尖瓣反流方面的巨大潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Revista Brasileira de Cardiologia Invasiva (English Edition)

自引率

0.00%

发文量